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Supplemental Figure 1. 
 
Fig. S1.SAXS spectra for SUVs alone. To facilitate visualization, spectra have been manually 
offset in the vertical direction by scaling each trace by a multiplicative factor.  
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Supplemental Figure 2. 
 
Fig. S2.Protein-only SAXS spectra for all proteins tested in this study. To facilitate visualization, 
spectra have been manually offset in the vertical direction by scaling each trace by a multiplicative 
factor.  
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Supplemental Figure 3. 
 
Fig. S3.SAXS spectra for XCL1 structural variants incubated with model mammalian cell 
membranes (DOPS/DOPE/DOPC 20/40/40). To facilitate visualization, spectra have been 
manually offset in the vertical direction by scaling each trace by a multiplicative factor.  
 
